Hoosier Cancer Research Network
Michelle Holliday has a Bachelor of Science degree in Criminal Justice and Criminology from Ball State University. Michelle has held various regulatory and clinical research roles, including Senior Regulatory Manager at Hoosier Cancer Research Network, Regulatory Manager at Franciscan Health, and Clinical Research Coordinator. In their positions, Michelle has been responsible for overseeing regulatory compliance, organizing IRB meetings, managing IRBNet, site activation for multiple therapeutic areas, maintaining regulatory documents, creating informed consent documents, and submitting clinical trials for review.
This person is not in the org chart
Hoosier Cancer Research Network
Hoosier Cancer Research Network, Inc., formerly known as Hoosier Oncology Group, is an independent nonprofit contract research organization (CRO) that specializes in early phase multi-center, investigator-initiated oncology clinical trials. Our studies are conducted through a nationwide network of more than 450 academic and community sites. Our highly qualified team provides comprehensive study management including budgeting, contracting, LOI submission, study design, regulatory and IND support, custom EDC development and validation, safety reporting, monitoring, site management, correlative management, data management, and support for publication. Hoosier Cancer Research Network’s vision and mission is to form unparalleled relationships between academic, community, pharmaceutical, and biotech collaborators with the goal of advancing cancer research, education, and patient advocacy.